TY - JOUR
T1 - Hypertension prevalence, awareness, treatment, and control in Egypt
T2 - Results from the Egyptian National Hypertension Project (NHP)
AU - Ibrahim, M. Mohsen
AU - Rizk, Hussein
AU - Appel, Lawrence J.
AU - El Aroussy, Wafaa
AU - Helmy, Sherif
AU - Sharaf, Yasser
AU - Ashour, Zeinab
AU - Kandil, Hossam
AU - Roccella, Edward
AU - Whelton, Paul K.
PY - 1995/12
Y1 - 1995/12
N2 - This report from the Egyptian National Hypertension Project presents national estimates of the prevalence of hypertension an the extent to which high blood pressure is being detected, treated with medications, and controlled din the Egyptian population. The results are based on findings from a national probability survey of adults ≥25 years of age conducted in six Egyptian governorates. With the use of a stratified multistage probability design, 6733 people (85% response rate) were examined. Hypertension was defined as systolic pressure ≥140 mm Hg, and/or diastolic presence pressure ≥90 mm Hg, and/or reported treatment with one or more antihypertensive medications. Overall, the estimated prevalence of hypertension in Egypt was 26.3%. Hypertension prevalence increased progressively with age, from 7.8% in 25- to 34-year-olds to 56.6% in those 75 years or older. Hypertension was slightly more common in women than in men (26.9% versus 25.7%, respectively). Overall, 37.5% of hypertensive individuals were aware that they had high blood pressure, 23.9% were being treated with antihypertensive medications, an 8.0% were under control (systolic pressure <140 mm Hg and diastolic pressure <90 mm Hg). Hypertension prevalence as well as awareness, treatment, and control rates varied by region, with Cairo having the highest control rate (15.9%). Rates of awareness, treatment, and control tended to be lowest in areas of lower socioeconomic status. Our results indicate that hypertension is highly prevalent in Egypt and that the rates of hypertension awareness, treatment, and control are relatively low. These findings argue for a nationwide effort to prevent and control high blood pressure in Egypt in order to avert an epidemic of cardiovascular disease.
AB - This report from the Egyptian National Hypertension Project presents national estimates of the prevalence of hypertension an the extent to which high blood pressure is being detected, treated with medications, and controlled din the Egyptian population. The results are based on findings from a national probability survey of adults ≥25 years of age conducted in six Egyptian governorates. With the use of a stratified multistage probability design, 6733 people (85% response rate) were examined. Hypertension was defined as systolic pressure ≥140 mm Hg, and/or diastolic presence pressure ≥90 mm Hg, and/or reported treatment with one or more antihypertensive medications. Overall, the estimated prevalence of hypertension in Egypt was 26.3%. Hypertension prevalence increased progressively with age, from 7.8% in 25- to 34-year-olds to 56.6% in those 75 years or older. Hypertension was slightly more common in women than in men (26.9% versus 25.7%, respectively). Overall, 37.5% of hypertensive individuals were aware that they had high blood pressure, 23.9% were being treated with antihypertensive medications, an 8.0% were under control (systolic pressure <140 mm Hg and diastolic pressure <90 mm Hg). Hypertension prevalence as well as awareness, treatment, and control rates varied by region, with Cairo having the highest control rate (15.9%). Rates of awareness, treatment, and control tended to be lowest in areas of lower socioeconomic status. Our results indicate that hypertension is highly prevalent in Egypt and that the rates of hypertension awareness, treatment, and control are relatively low. These findings argue for a nationwide effort to prevent and control high blood pressure in Egypt in order to avert an epidemic of cardiovascular disease.
KW - Egypt
KW - blood pressure
KW - data collection
KW - health services research
KW - prevalence
UR - http://www.scopus.com/inward/record.url?scp=0028786930&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028786930&partnerID=8YFLogxK
U2 - 10.1161/01.HYP.26.6.886
DO - 10.1161/01.HYP.26.6.886
M3 - Article
C2 - 7490144
AN - SCOPUS:0028786930
SN - 0194-911X
VL - 26
SP - 886
EP - 890
JO - Hypertension
JF - Hypertension
IS - 6 I
ER -